BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24529623)

  • 1. EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma.
    Zhang B; Wang H; Liao Z; Wang Y; Hu Y; Yang J; Shen S; Chen J; Mei H; Shi W; Hu Y; Pang Z; Jiang X
    Biomaterials; 2014 Apr; 35(13):4133-45. PubMed ID: 24529623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Antitumor Activity of EGFP-EGF1-Conjugated Nanoparticles by a Multitargeting Strategy.
    Zhang B; Jiang T; Ling L; Cao Z; Zhao J; Tuo Y; She X; Shen S; Jiang X; Hu Y; Pang Z
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):8918-27. PubMed ID: 26890991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery.
    Mei H; Shi W; Pang Z; Wang H; Lu W; Jiang X; Deng J; Guo T; Hu Y
    Biomaterials; 2010 Jul; 31(21):5619-26. PubMed ID: 20413154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
    Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
    Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma.
    Zhang B; Zhang Y; Liao Z; Jiang T; Zhao J; Tuo Y; She X; Shen S; Chen J; Zhang Q; Jiang X; Hu Y; Pang Z
    Biomaterials; 2015 Jan; 36():98-109. PubMed ID: 25443789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy.
    Shi W; Yin Y; Wang Y; Zhang B; Tan P; Jiang T; Mei H; Deng J; Wang H; Guo T; Pang Z; Hu Y
    Oncotarget; 2017 May; 8(19):32212-32227. PubMed ID: 27793028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tissue factor targeted nanomedical system for thrombi-specific drug delivery.
    Shi W; Mei H; Deng J; Chen C; Wang H; Guo T; Zhang B; Li L; Pang Z; Jiang X; Shen S; Hu Y
    Biomaterials; 2012 Oct; 33(30):7643-54. PubMed ID: 22819496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles.
    Zhang B; Shen S; Liao Z; Shi W; Wang Y; Zhao J; Hu Y; Yang J; Chen J; Mei H; Hu Y; Pang Z; Jiang X
    Biomaterials; 2014 Apr; 35(13):4088-98. PubMed ID: 24513320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
    Cui Y; Xu Q; Chow PK; Wang D; Wang CH
    Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels.
    Hu Q; Gao X; Kang T; Feng X; Jiang D; Tu Y; Song Q; Yao L; Jiang X; Chen H; Chen J
    Biomaterials; 2013 Dec; 34(37):9496-508. PubMed ID: 24054848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
    Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
    Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy.
    Feng X; Yao J; Gao X; Jing Y; Kang T; Jiang D; Jiang T; Feng J; Zhu Q; Jiang X; Chen J
    ACS Appl Mater Interfaces; 2015 Dec; 7(50):27885-99. PubMed ID: 26619329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
    Kang T; Gao X; Hu Q; Jiang D; Feng X; Zhang X; Song Q; Yao L; Huang M; Jiang X; Pang Z; Chen H; Chen J
    Biomaterials; 2014 May; 35(14):4319-32. PubMed ID: 24565520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.
    Hu Q; Gao X; Gu G; Kang T; Tu Y; Liu Z; Song Q; Yao L; Pang Z; Jiang X; Chen H; Chen J
    Biomaterials; 2013 Jul; 34(22):5640-50. PubMed ID: 23639530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
    Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
    Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.
    Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J
    Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
    Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
    Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein.
    Huile G; Shuaiqi P; Zhi Y; Shijie C; Chen C; Xinguo J; Shun S; Zhiqing P; Yu H
    Biomaterials; 2011 Nov; 32(33):8669-75. PubMed ID: 21843903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
    Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J
    Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.